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ABSTRACT
Purpose: It is difficult to assess airway obstruction using spirometry in adult asthmatic 
patients with preserved lung function. Impulse oscillometry (IOS) can detect not only airway 
resistance but also reactance. Therefore, IOS may be useful in assessing pulmonary function 
in such patients. We investigated the applicability of IOS for asthma patients with preserved 
lung function.
Methods: Between 2015 and 2018, 1,248 adult asthmatic patients suspected of having asthma 
who visited the Allergy and Asthma Center of Severance Hospital underwent both spirometry 
and IOS. Consequently, 784 patients had asthma, 111 had chronic obstructive lung disease 
(COPD) or asthma-COPD overlap, and 7 had parenchymal lung disease. The remaining 
346 patients had chronic cough without underlying lung or airway disease. Among the 784 
asthmatic patients, 191 with decreased lung function (predicted forced expiratory volume 
in 1 second [FEV1] < 80%) were excluded. Propensity score matching was performed to 
adjust baseline characteristics between 346 non-asthmatic and 593 asthmatic patients with 
preserved lung function. Subsequently, we compared the spirometry and IOS parameters 
between the 329 asthmatic and 329 non-asthmatic patients.
Results: Multiple logistic regression analysis showed that the area of reactance (AX) was 
associated with asthma with preserved lung function. In receiver operating characteristic 
(ROC) curve analysis, the area under the curve (AUC) of AX (AUC = 0.6823) for asthma 
was not significantly different from that of FEV1 (AUC = 0.6758). However, the AUC of a 
combination of AX and FEV1 (AUC = 0.7437) for asthma was significantly higher than that of 
FEV1 alone. The cutoff value of AX was 0.51 kPa/L in univariate ROC analysis.
Conclusions: AX is associated with adult asthma with preserved lung function. Performing 
spirometry together with IOS is more beneficial than performing spirometry alone for 
diagnosing asthma in adult patients with preserved lung function.
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INTRODUCTION
Many asthmatic patients have preserved lung function (predicted forced expiratory volume 
in 1 second [FEV1] ≥ 80%),1,2 despite having asthma symptoms.3 Therefore, although 
spirometry is the most commonly used procedure to assess pulmonary function,4-7 it is 
limited in assessing asthma in patients with normal airway flow. In these patients, the 
bronchial challenge test may be helpful in confirming a diagnosis of asthma.8 However, it 
may be difficult to detect asthma using this challenge test alone.9,10 Therefore, the diagnosis 
of asthma is confirmed by considering various factors such as patient history, physical 
examination, the presence of reversible airway obstruction and airway hyperresponsiveness, 
patient response to treatment, and results of additional tests (blood and sputum analysis, 
fractional exhaled nitric oxide levels, etc.).8 However, it is still difficult to diagnose asthma 
in some patients with preserved lung function, and there is an unmet need for additional 
diagnostic tools.
Unlike spirometry which measures the volume displacement of air through forceful 
expiratory and inspiratory maneuvers, impulse oscillometry (IOS) measures changes in 
the pressure and flow of the airway, which are then mapped to mechanical resistances 
and reactances.11 Therefore, it has been suggested that IOS can detect peripheral airway 
impairment at an early stage and reflects the elasticity of the peripheral airway.11,12 However, 
due to the excellent accessibility of spirometry, IOS is mainly used in children who face 
difficulties in undergoing spirometry and is not commonly used for adults.13 Therefore, 
there have been limited studies on the applicability of IOS in adult asthmatic patients with 
preserved lung function. Considering the limitation of spirometry in patients with preserved 
lung function, performing IOS in such patients may be beneficial, and the forced expiration 
process during spirometry is difficult to perform in adults, especially patients with fatigue, 
comorbid medical conditions, sensory deficits, coordination impairments, or cognitive 
impairments.14-16 In contrast, because IOS is an effort-independent modality,16 its parameters 
are measured during the normal breathing process. Its parameters can be easily measured in 
most patients.
The Allergy and Asthma Center of Severance Hospital has performed spirometry and IOS in 
adults suspected to have asthma. In this study, we aimed to investigate the applicability of 
IOS in the diagnosis of adult asthmatic patients with preserved lung function. We analyzed 
adult patients who underwent spirometry and IOS from 2015 to 2018.
MATERIALS AND METHODS
Patients
From 2015 to 2018, 1,248 adult patients suspected of having asthma who underwent both 
spirometry and IOS were enrolled in this study (Fig. 1) Consequently, 784 patients had 
asthma, 111 had chronic obstructive lung disease (COPD) or asthma-COPD overlap, 7 had 
parenchymal lung disease, and 346 had chronic cough without underlying lung or airway 
disease. Among the asthmatic patients, 191 with decreased lung function (predicted FEV1 < 
80%) were excluded. After adjusting baseline characteristics such as sex, age, weight, and 
body mass index (BMI), propensity score matching was performed with the remaining 593 
asthmatic patients with preserved FEV1 (predicted FEV1 ≥ 80%) and 346 non-asthmatic 
patients. We then compared and analyzed spirometry and IOS parameters in 329 asthmatic 
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patients with preserved lung function with those in 329 non-asthmatic patients. This study 
was approved by the hospital's medical ethics committee (4-2019-0530). The need for 
informed consent was exempted.
Diagnosis of patients
The medical records of 1,248 patients were retrospectively reviewed. Patients were diagnosed 
with asthma based on their clinical histories involving variable respiratory symptoms, their 
responses to inhaled corticosteroids, presence of elevated sputum eosinophil levels, and 
results of the bronchial challenge test.17 Patients who had tuberculosis or interstitial lung 
disease according to chest radiography or computed tomography were diagnosed with 
parenchymal lung disease. Patients who had persistent peripheral airway obstruction (FEV1/
forced vital capacity [FVC] ratio < 70%) after bronchodilator inhalation were diagnosed with 
COPD or asthma-COPD overlap. Patients who had chronic cough lasting for more than 2 
months with preserved lung function and without asthma evidence or parenchymal lung 
disease as mentioned above were diagnosed as non-asthmatics.
Propensity score matching
A propensity score is the probability that a unit with certain characteristics will be assigned 
to the asthma group (as opposed to the non-asthma group).18 These scores can be used 
to reduce or eliminate selection bias in observational studies by balancing covariates 
(the characteristics of participants) between the asthma and non-asthma groups. When 
the covariates are balanced, it becomes much easier to match participants with multiple 
characteristics. This is one of the best alternatives to reduce bias in sample selection when 
structural randomization is not possible. Therefore, a propensity score matching method was 
used to match in a 1:1 ratio in order to reduce bias. First, we performed a univariate analysis 
between the asthma and non-asthma groups, confirmed differences in age, sex, height, and 
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Patients undergoing spirometry and IOS
with suspected asthma: 1,248




with preserved lung function
(predicted FEV1 ≥ 80%): 593
Asthmatic patients
with preserved lung function:
329
Asthmatic patients
with decreased lung function





(sex, age, height, BMI)
Propensity score matching
with non-asthma patients
(sex, age, height, BMI)
Non-asthmatic patients:
329
Fig. 1. Patients investigated in this study.
BMI, and used these as matching covariates. After matching, analysis was performed with 
reduced bias.
IOS
IOS parameters were collected before conventional spirometry parameters using the 
MasterLab IOS System (Erich Jaeger, Würzburg, Germany). Calibration was performed 
using a single volume of air (3 L) at different flow rates and a reference resistance device 
(0.2 kPa/L/s). The patients wore a nose clip and a manufacturer-provided, oval, hard plastic 
mouthpiece to prevent the expired air from escaping. They were also requested to support 
their cheeks with their hands to decrease shunt compliance. Artifacts caused by coughing, 
breath holding, swallowing, and vocalization were not included. A single, experienced, 
respiratory technician made all the IOS measurements. The parameters evaluated were 
resonant frequency (Fres), resistance at 5 Hz (R5), resistance at 20 Hz (R20), difference 
between the resistance at 5 and 20 Hz (R5–R20), reactance at 5 Hz (X5), area of reactance 
(AX), and impedance at 5 Hz (Z5) as calculated by �𝑋𝑋𝑋𝑋52 + 𝑅𝑅𝑅𝑅52 .
Spirometry
In all patients, spirometric measurements were taken 5 minutes after IOS measurements. The 
maximal expiratory flow volume measurements were obtained using a pneumotachometer 
system equipped with a Lilly head (MasterScreen system; Erich Jaeger). International criteria 
were used to determine the spirometric flow-volume curve.19 The patients used a nose clip 
and were instructed in the standard forced expiratory maneuver. Each data set consisted 
of results associated with at least 3 reproducible attempts, with no more than 8 attempts 
made per patient. The best result from the 3 attempts was chosen for final data analysis. 
The measurement of lung function was repeated 20 minutes after albuterol administration. 
Albuterol was administered in 3 puffs of 100 μg through a pressurized metered dose inhaler.
Bronchial challenge test
Methacholine was diluted in an isotonic sodium chloride solution and was administered 
using a handheld nebulizer (Devilbis 646; Devilbis Health Care, Somerset, UK) that 
was connected to a Rosental dosimeter (Devilbis Health Care). Each patient took 5 full 
inhalations from functional residual capacity to total lung capacity without a period of 
breath holding after each full inspiration. The initial concentration of methacholine 
that was administered was 0.075 mg/mL, and a dose-response curve was constructed by 
administering a serial doubling of this concentration of methacholine until a concentration 
of 25 mg/mL was reached. The provocation concentration that caused a decrease of 20% 
(PC20) in FEV1 was calculated by a linear interpolation between the last 2 points on the dose-
response curve. If the PC20 value was ≤16 mg/mL, the airway was considered positive for 
hyperresponsiveness. The asthma challenge test was performed 2 weeks after measuring IOS 
and spirometry parameters.
Induced sputum analysis
Sputum was induced by the inhalation of 3% saline via a nebulizer (ULTRA-NEB 2000; 
Devilbis Health Care). We mixed 1 mL of sputum with an equal volume of 10% sputolysin 
(0.1% dithiothreitol in phosphate-buffered saline; Calbiochem-Novabiochem, San Diego, 
CA, USA) and mildly homogenized it by vortexing for 1 minute. After incubation in a shaking 
water bath for 20 minutes, the cells were centrifuged at 1,500 rpm for 3 minutes. The 
resulting cell pellets were resuspended with saline and were cytocentrifuged at 1,000 rpm 
for 3 minutes onto a slide using the Cytospin 3 (Shandon; Cheshire, United Kingdom). After 
835https://e-aair.org https://doi.org/10.4168/aair.2020.12.5.832
IOS for Adult Asthma With Preserved Lung Function
Wright and Giemsa staining, up to 200 inflammatory cells were counted and eosinophil 
percentages were calculated. If the eosinophil percentage was ≥ 3%, the sputum was 
considered eosinophil-positive. The sputum analysis was performed following spirometry 
and IOS on the same day.
Statistical analysis
Continuous variables are expressed as mean ± standard deviation and was compared 
using an independent 2 sample t test. Categorical variables are expressed as numbers and 
percentages and were compared using a χ2 test or Fisher's exact test. To adjust differences 
in baseline characteristics between the non-asthmatic and asthmatic patients, propensity 
score matching (1:1) was performed. Age, sex, height, and BMI were used as covariates for 
matching. Multiple logistic regression was performed to identify factors associated with the 
composite outcome. The areas under the curves (AUCs) and their 95% confidence intervals 
(CIs) were calculated using the nonparametric method suggested by DeLong et al.19 The 
cutoff values were determined by using Youden's index.20 Statistical significance was assessed 
by P values < 0.05, and 95% CIs were constructed. Statistical software (SAS 9.4, SAS Institute; 
Cary, NC, USA) was used for statistical analyses.
RESULTS
Demographic data
FVC (predicted %), FEV1 (L), FEV1 (predicted %), and FEV1/FVC (%) were lower in 
asthmatic patients than in non-asthmatic patients; the bronchodilator (BD) response (L) 
and BD response (%) were higher in asthmatic patients than in non-asthmatic patients 
(Supplementary Table S1). There were more atopic patients among asthmatic patients than 
among non-asthmatic patients. A sputum eosinophil percentage of ≥ 3% was observed in 
51.1% of the asthmatic patients, and 30.7% of the asthmatic patients had positive results 
in the asthma challenge test. AX, Fres, R5, R20, and R5–R20 values were higher and X5 
values were lower in asthmatic patients than in non-asthmatic patients. Due to differences 
in baseline characteristics, such as sex, age, height, and BMI, between non-asthmatic and 
asthmatic patients, which could affect IOS parameters, propensity score matching was 
performed using these factors. The significant difference in spirometry and IOS parameter 
values remained after propensity score matching (Table 1).
Multiple logistic regression and receiver operating characteristic (ROC) analyses
Multiple logistic regression analysis was performed with a model containing spirometry 
parameters, a model containing IOS parameters, and a model containing all parameters of 
both tests (Table 2). In the model containing all parameters of both tests, FEV1 (predicted %, 
P < 0.0001), AX (P < 0.0001), and Fres (P = 0.0198) were significantly associated with asthma. 
In the spirometry parameter model, FEV1 (L, P = 0.0289) and FEV1 (predicted %, P < 0.0001) 
were significantly associated with asthma. In the IOS parameter model, AX was significantly 
associated with asthma (P < 0.0001). Multiple logistic regression analyses of selected parameter 
models were performed to compare AUC values of significant parameters. In the selected 
parameter models, FEV1 (L, P = 0.0112), FEV1 (predicted %, P < 0.0001), and AX (P < 0.0001) 
were significantly associated with asthma.
ROC curves were plotted based on predictive scoring equations from the results of the 
multiple logistic regression analyses. The AUC of all parameter models of both tests was 
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0.7891, that of the selected parameter model of both tests (FEV1 [predicted %], FEV1 [L] 
and AX) was 0.7437, that of the selected spirometry parameter model (FEV1 [predicted %] 
and FEV1 [L]) was 0.6758, and that of the selected IOS parameter model (AX) was 0.6823 
(Fig. 2). No significant difference was observed in the AUC value between the selected 
spirometry parameters and selected IOS parameter models (P = 0.8028). However, there 
was a significant difference in the AUC value between all parameter and selected spirometry 
parameter models (P < 0.0001), and between the selected parameters of both tests and 
selected spirometry parameter model (P < 0.0001).
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Table 1. Demographic data of non-asthmatic and asthmatic patients with preserved lung function after 
propensity score matching
Characteristics Non-asthmatic patients Asthmatic patients P value
Patient number 329 329
Sex (male:female) 148:181 146:183 0.8754
Age (yr) 51.1 ± 15.1 50.6 ± 17.1 0.7026
Height (cm) 163.5 ± 8.7 163.3 ± 8.3 0.7208
Body weight (kg) 63.0 ± 11.7 62.9 ± 11.2 0.8503
BMI (kg/m2) 23.5 ± 3.5 23.5 ± 3.1 0.8503
FVC (predicted %) 105.65 ± 13.63 100.87 ± 12.21 < 0.0001
FEV1 (L) 2.99 ± 0.77 2.79 ± 0.78 0.0008
FEV1 (predicted %) 104.55 ± 14.02 97.04 ± 12.08 < 0.0001
BD response (L) 0.079 ± 0.080 0.131 ± 0.130 < 0.0001
BD response (%) 2.67 ± 2.59 4.73 ± 4.38 < 0.0001
FEV1/FVC (%) 82.4 ± 6.4 80.2 ± 7.3 < 0.0001
AX (kPa/L) 0.341 ± 0.190 0.712 ± 0.789 < 0.0001
Fres (Hz) 13.121 ± 2.692 15.313 ± 4.182 < 0.0001
R5 (kPa/L/s) 0.304 ± 0.077 0.370 ± 0.129 < 0.0001
R20 (kPa/L/s) 0.231 ± 0.065 0.256 ± 0.071 < 0.0001
R5–R20 (kPa/L/s) 0.073 ± 0.041 0.114 ± 0.077 < 0.0001
X5 (kPa/L/s) −0.097 ± 0.035 −0.128 ± 0.082 < 0.0001
Z5 (kPa/L/s) 0.320 ± 0.079 0.394 ± 0.146 < 0.0001
Propensity score matching (1:1) was performed between the non-asthma and asthma patients. Age, sex, height, 
and BMI were used as covariates for matching. Continuous variables are expressed as mean ± standard deviation 
and were compared using an independent 2-sample t test. Categorical variables are expressed as numbers and 
percentages, and were compared using a χ2 test or Fisher's exact test.
BMI, body mass index; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second; BD, bronchodilator; 
AX, area of reactance; Fres, resonant frequency; R5, resistance at 5 Hz; R20, resistance at 20 Hz; R5–R20, 
difference between the resistance at 5 Hz and 20 Hz; X5, reactance at 5 Hz; Z5, impedance at 5 Hz.
Table 2. Multiple logistic regression analyses of spirometry and IOS parameters for asthma in adults with preserved lung function
Parameters All parameters model 
of both tests
Selected parameters 





IOS parameters model Selected IOS 
parameters model
Estimate p value Estimate p value Estimate p value Estimate p value Estimate p value Estimate p value
FEV1 (L) 0.2703 0.1646 −0.3478 0.0289 −0.2784 0.0112
FEV1 (predicted %) −0.0402 < 0.0001 −0.0459 < 0.0001 −0.0382 < 0.0001 −0.0453 < 0.0001
BD response (L) 1.1672 0.7393 2.7819 0.3689
BD response (%) 0.1260 0.2439 0.0597 0.5163
FEV1/FVC (%) −0.00157 0.9183 −0.00071 0.9591
AX (kPa/L) 5.8004 < 0.0001 3.2436 < 0.0001 5.4102 < 0.0001 2.6891 < 0.0001
Fres (Hz) −0.1369 0.0198 −0.0722 0.1423 −0.0920 0.0812
R5 (kPa/L/s) −4.8246 0.2368 31.7721 0.4577
R5–R20 (kPa/L/s) 28.3540 0.5301 −3.1906 0.4251
X5 (kPa/L/s) 2.4889 0.8725 2.0470 0.8883
Z5 (kPa/L/s) −27.7076 0.5561 −33.2542 0.4566
Multiple logistic regression analyses were performed with several models. Statistically significant variables in multiple logistic regression analysis were chosen as 
selected parameters.
IOS, impulse oscillometry; FEV1, forced expiratory volume one second; BD, bronchodilator; AX, area of reactance; Fres, resonant frequency; R5, resistance at 5 
Hz; R20, resistance at 20 Hz; R5–R20, difference between the resistance at 5 Hz and 20 Hz; X5, reactance at 5 Hz; Z5, impedance at 5 Hz.
Scatter plot and cutoff values
Scatter plot of FEV1 (predicted %) and AX are shown in Fig. 3. There was no linear correlation 
between the 2 parameters in patients with preserved lung function. Non-asthmatic and 
asthmatic patients overlapped in most FEV1 ranges. However, many asthmatic patients 
showed high AX, regardless of the FEV1 value. Cutoff values were calculated using univariate 
ROC analysis (Table 3). The cutoff value of AX was 0.51 kPA/L, and FEV1 (predicted %) was 
94%. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value 
(NPV) of AX were higher than that of FEV1 (predicted %). Scatter plot and cutoff values of all 
parameters are shown in Supplementary Table S2 and Supplementary Fig. S1.
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Fig. 2. ROC curve analysis of spirometry and IOS parameters for predicting asthma in adults with preserved 
lung function. ROC curves were plotted based on predictive scoring equations from multiple logistic regression 
analyses. The AUC values were calculated on the basis of the multiple logistic regression models. All parameter 
models of both tests included FEV1 (L), FEV1 (%), BD response (L), BD response (%), FEV1/FVC (%), AX (kPa/L), 
Fres (Hz), R5 (kPa/L/s), R5–R20 (kPa/L/s), X5 (kPa/L/s), and Z5 (kPa/L/s). The selected parameter models of 
both tests included FEV1 (%) and AX (kPa/L). The selected spirometry parameter model included FEV1 (L) and 
FEV1 (%). The selected IOS parameter model included AX (kPa/L). AUC values of each model were compared by 
DeLong's method. 
ROC, receiver operating characteristic; AUC, area under the curve; FEV1, forced expiratory volume in 1 second; 
BD, bronchodilator; AX, area of reactance; Fres, resonant frequency; R5, resistance at 5 Hz; R20, resistance at 20 
Hz; R5–R20, difference between the resistance at 5 Hz and 20 Hz; X5, reactance at 5 Hz; Z5, impedance at 5 Hz.
Table 3. Cutoff values for asthma in adults with preserved lung function
Parameters Cut-off value AUC YJ Sensitivity Specificity PPV NPV
FEV1 (%) 94.0112 0.6692 0.27356 46.5046 80.8511 70.8333 60.1810
AX (kPa/L) 0.51000 0.6868 0.32313 49.3865 82.9268 74.1935 62.2426
Univariate receiver operating characteristic curve analysis was performed using these parameters, and the cutoff values were then determined using Youden's index.
AUC, area under the curve; YJ, Youden's J; FEV1, forced expiratory volume in 1 second; AX, area of reactance; PPV, positive predictive value; NPV, negative 
predictive value.
DISCUSSION
In this study, we demonstrated the applicability of IOS in diagnosing asthma in adult patients 
with preserved lung function. AX was significantly associated with asthma in these patients, 
and AX showed a similar AUC value as FEV1 when compared using ROC curves. Furthermore, 
the model of AX and FEV1 had a significantly higher AUC value for asthma than that of FEV1. 
In addition, AX had higher sensitivity, specificity, PPV, and NPV for asthma than FEV1 in 
these patients. Considering these results, performing spirometry and IOS together can help 
clinician diagnose adult asthma.
Compared with non-asthmatic airways, the inflammation of asthmatic airways results in 
an altered airway composition.21 Moreover, airway remodeling can also occur in asthmatic 
airways.22 Generally, these changes are evident in patients with severe asthma.23,24 However, 
this can also occur in asthmatic patients with preserved lung function. Subepithelial 
fibrosis has been observed in these patients.25-27 Such differences in cell composition and 
physical layers of the airway shift the structural and mechanical resonances of the airway 
and lead to different frequency response coefficients associated with resonance, which 
eventually translates to different impedance values.28 When the airway is excited due to the 
IOS examination, such changes in the frequency domain clearly manifest as differences in 
IOS outcomes. Therefore, IOS can detect airway changes that do not affect airway flow. As 
a result, IOS can be useful for asthma diagnosis, especially in patients whose spirometric 
results show normal lung function.
The multiple logistic regression analysis of all parameters showed that among IOS 
parameters, AX and Fres were associated with asthma. However, the estimate of −0.1369 for 
Fres indicated that the risk of asthma was reduced when Fres increased. It is known that Fres 
is higher in asthmatic patients than in healthy subjects,29 and Fres had a higher mean value 
in asthmatic patients than in non-asthmatic patients in this study. This paradoxical result is 
associated with a higher standard deviation of the Fres value in asthmatic patients than in 
non-asthmatic patients. This affected the results of multiple logistic regression following 
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Fig. 3. Scatter-plot of FEV1 and AX. There was no linear correlation between the 2 parameters. 
FEV1, forced expiratory volume in 1 second; AX, area of reactance.
propensity score matching. Therefore, we considered that AX was the only valid parameter in 
this analysis. An accurate interpretation of this result requires further analysis with a larger 
sample size.
AX is the area under the curve of reactance between 5 Hz and Fres30 and reflects the elastic 
properties of the lung.11 In this study, although we enrolled asthmatic patients who had 
preserved lung function in spirometry, the patients might have had asthmatic inflammation 
in their airways. Therefore, this inflammation could have affected airway elasticity, resulting 
in an abnormal AX. In contrast, multiple logistic regression analysis showed that the R5–R20, 
which reflects peripheral airway resistance,31 was not associated with asthma in these patients. 
Relatively small changes in the airway of asthmatic patients who had normal airway flow might 
not affect the R5 change in a clinically meaningful way. Therefore, we suggest that among IOS 
parameters, AX is the most useful parameter for the diagnosis of asthma in adult patients who 
have preserved lung function in spirometry.
An important advantage of IOS is that it can be measured during normal breathing. IOS 
examines the airway via frequency excitations. IOS superimposes multiple sound waves 
with different frequency components on a patient's normal tidal breathing.11 The multiple 
frequency components propagate into various parts of the lung. Frequency components 
are reflected back at different rates due to the complex physical structure and nonuniform 
frequency response of the lung. Pressure changes and flows can be determined by comparing 
incident waves and reflected waves at various frequencies, and corresponding mechanical 
resistance and reactance (impedance) can be calculated at each frequency. The resistances 
and impedances at different frequencies map to different regions in the lung. Because tidal 
breathing is at much lower frequency components (< 1 Hz) compared with relevant frequency 
components (5–25 Hz) for IOS, a simple low-frequency filter implemented during IOS 
accurately processes signals, and consequently, data extraction can be completed. Therefore, 
IOS can be performed during normal tidal breathing with a remarkably low volume of air 
being displaced. Furthermore, this is a relatively short procedure. As a result, performing 
spirometry following IOS measurements dose not burden patients.
This study has some limitations. First, we did not consider the effects of medications; 
some patients were already using inhaled corticosteroid (ICS) when undergoing spirometry 
and IOS. The AUCs of spirometry and IOS parameters might be undervalued. However, 
subgroup analysis showed that the mean values of parameters of naive ICS users did not 
significantly differ from those of continuous ICS users. Therefore, effects of medications 
might not have significantly affected the AUCs of parameters. Secondly, asthma is not the 
only condition that can show abnormal IOS values. Airway diseases, such as bronchitis, 
emphysema, bronchiectasis, COPD, and interstitial lung disease, can also show abnormal 
IOS values.32-34 Therefore, it is always necessary to discriminate among these diseases that 
may affect IOS values. Thirdly, although there are many reference values associated with 
adult IOS,13,35-38 there are no clear reference values for adult asthma. Because IOS values 
were reported to depend on age, sex, height, body weight, BMI, and race,13,39 it is difficult to 
establish clear reference values. The cutoff values for IOS parameters suggested in this study 
did not consider multiple interactions among the parameters. Therefore, further research 
is needed to determine appropriate reference values that can aid in the diagnosis of adult 
asthma. Despite these limitations, the results of this study are clinically meaningful because 
we demonstrated that IOS is helpful in diagnosing asthma in adult patients with preserved 
lung function.
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In conclusion, AX is associated with asthma with preserved lung function. Performing 
spirometry and IOS together is more clinically useful for diagnosing these asthmatic patients 
than spirometry only.
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